Hemavant is a clinical-stage biopharmaceutical company dedicated to developing innovative targeted therapeutics to improve the lives of patients with blood disorders and hematological malignancies.
| Employees | 2 (1 on RocketReach) |
| Founded | 2022 |
| Industry | Pharmaceutical Manufacturing |
Looking for a particular Hemavant Sciences employee's phone or email?
David Turnquist is the Vice President, CMC of Hemavant Sciences.
1 people are employed at Hemavant Sciences.